436 related articles for article (PubMed ID: 33229321)
21. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.
Meisel R
N Engl J Med; 2021 Jun; 384(23):e91. PubMed ID: 34107195
[No Abstract] [Full Text] [Related]
22. [Recent developments in enhancing the efficiency of CRISPR/Cas9- mediated knock-in in animals].
Li GL; Yang SX; Wu ZF; Zhang XW
Yi Chuan; 2020 Jul; 42(7):641-656. PubMed ID: 32694104
[TBL] [Abstract][Full Text] [Related]
23. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. Reply.
Frangoul H; Ho TW; Corbacioglu S
N Engl J Med; 2021 Jun; 384(23):e91. PubMed ID: 34107197
[No Abstract] [Full Text] [Related]
24. [Advances in AAV-CRISPR/Cas9-Mediated Hemophilia A Gene Therapy --Review].
Fang S; Wang G; Yang LH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1890-1893. PubMed ID: 38071078
[TBL] [Abstract][Full Text] [Related]
25. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
Liu W; Yang C; Liu Y; Jiang G
Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
[TBL] [Abstract][Full Text] [Related]
26. Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia.
Parums DV
Med Sci Monit; 2024 Mar; 30():e944204. PubMed ID: 38425279
[TBL] [Abstract][Full Text] [Related]
27. Creating cell and animal models of human disease by genome editing using CRISPR/Cas9.
Zarei A; Razban V; Hosseini SE; Tabei SMB
J Gene Med; 2019 Apr; 21(4):e3082. PubMed ID: 30786106
[TBL] [Abstract][Full Text] [Related]
28. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
[TBL] [Abstract][Full Text] [Related]
29. β-Thalassemia gene editing therapy: Advancements and difficulties.
Hu J; Zhong Y; Xu P; Xin L; Zhu X; Jiang X; Gao W; Yang B; Chen Y
Medicine (Baltimore); 2024 May; 103(18):e38036. PubMed ID: 38701251
[TBL] [Abstract][Full Text] [Related]
30. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
[TBL] [Abstract][Full Text] [Related]
31. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
Hong KQ; Liu DY; Chen T; Wang ZW
World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
[TBL] [Abstract][Full Text] [Related]
32. Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia.
Ye L; Wang J; Tan Y; Beyer AI; Xie F; Muench MO; Kan YW
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10661-5. PubMed ID: 27601644
[TBL] [Abstract][Full Text] [Related]
33. Progress and Application of CRISPR/Cas Technology in Biological and Biomedical Investigation.
Lin J; Zhou Y; Liu J; Chen J; Chen W; Zhao S; Wu Z; Wu N
J Cell Biochem; 2017 Oct; 118(10):3061-3071. PubMed ID: 28590031
[TBL] [Abstract][Full Text] [Related]
34. Progress and Perspective of CRISPR-Cas9 Technology in Translational Medicine.
Zheng R; Zhang L; Parvin R; Su L; Chi J; Shi K; Ye F; Huang X
Adv Sci (Weinh); 2023 Sep; 10(25):e2300195. PubMed ID: 37356052
[TBL] [Abstract][Full Text] [Related]
35. Lipid and polymer mediated CRISPR/Cas9 gene editing.
Gong Y; Tian S; Xuan Y; Zhang S
J Mater Chem B; 2020 May; 8(20):4369-4386. PubMed ID: 32364557
[TBL] [Abstract][Full Text] [Related]
36. CRISPR/Cas9-mediated gene correction in hemophilia B patient-derived iPSCs.
Morishige S; Mizuno S; Ozawa H; Nakamura T; Mazahery A; Nomura K; Seki R; Mouri F; Osaki K; Yamamura K; Okamura T; Nagafuji K
Int J Hematol; 2020 Feb; 111(2):225-233. PubMed ID: 31664646
[TBL] [Abstract][Full Text] [Related]
37. The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice.
Ou Z; Niu X; He W; Chen Y; Song B; Xian Y; Fan D; Tang D; Sun X
Sci Rep; 2016 Sep; 6():32463. PubMed ID: 27581487
[TBL] [Abstract][Full Text] [Related]
38. [Application of CRISPR/Cas9 mediated gene editing in trees].
Chen YN; Lu J
Yi Chuan; 2020 Jul; 42(7):657-668. PubMed ID: 32694105
[TBL] [Abstract][Full Text] [Related]
39. The Smart Programmable CRISPR Technology: A Next Generation Genome Editing Tool for Investigators.
Chakraborty C; Teoh SL; Das S
Curr Drug Targets; 2017; 18(14):1653-1663. PubMed ID: 27231109
[TBL] [Abstract][Full Text] [Related]
40. [Recent progresses in CRISPR genome editing in plants].
Li H; Xie K
Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1700-1711. PubMed ID: 29082718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
